Ali, Sapya S.

HRN: 10-74-98  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/13/2026
03/20/2026
IV
1.5g
Q6
Furuncle
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: